Borrelia burgdorferi Johnson et al. emend. Baranton et al. (ATCC® 55131)

Strain Designations: HB19M  /  Type Strain: no  /  Biosafety Level: 2

Permits And Restrictions

View Permits

Strain Designations HB19M
Application
Used to produce vaccine against Lyme disease
Emerging infectious disease research
Vector borne research
Isolation
Blood - human
Belgium
Type Strain no
Biosafety Level 2
Product Format frozen
Preceptrol® no
Type Strain no
Comments
Flagella-less mutant
Growth Conditions
Temperature: 37.0°C
Atmosphere: Aerobic
Name of Depositor AG Barbour
Isolation
Blood - human
Belgium
References

Barbour AG, Bundoc V. Flagella-less borrelia. US Patent 5,436,000 dated Jul 25 1995

human blood

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation